Navigation Links
CalciMedica Announces Issuance of US Patent No. 7,645,588, a Composition Patent Involving STIM1, a Key Component of the CRAC Channel
Date:2/16/2010

LA JOLLA, Calif., Feb. 16 /PRNewswire/ -- CalciMedica today announced that the US Patent and Trademark Office has issued to CalciMedica US Patent No. 7,645,588, a composition patent involving STIM1, a key component of the calcium release-activated calcium (CRAC) channel. The patent, entitled "Composition comprising a cell comprising a STIM1 protein and an agent that modulates intracellular calcium and methods of use," has a priority date of March 4, 2003 and was issued on January 12, 2010. The compositions covered by the patent include both a recombinant cell expressing the STIM1 protein and an agent that reduces calcium ion stores in the cell.

The CRAC channel is the gatekeeper for the Icrac-NFAT pathway, a network essential for the adaptive immune response. STIM1, a calcium sensor in the endoplasmic reticulum, interacts with Orai1, the CRAC channel subunit in the plasma membrane, to regulate calcium entry into T cells. The composition of matter claims can be used for multiple purposes, including assays for the discovery of agents that modulate the activity of CRAC channels. These agents, in turn, can be developed for the treatment of autoimmune diseases, such as rheumatoid arthritis, psoriasis, multiple sclerosis, ulcerative colitis as well as organ transplant rejection and other diseases of the immune system, such as allergy and asthma.

"Establishing patent protection of the STIM1 technology, a key component of our drug discovery platform, is an important achievement for CalciMedica," said Gonul Velicelebi, PhD, Chief Executive Officer of CalciMedica and co-inventor on the patent. "We have made great strides in using this technology to identify novel small molecule CRAC channel inhibitors and validating the potential of the CRAC channel as a therapeutic target. We are advancing to investigational
'/>"/>

SOURCE CalciMedica, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... AUSTIN, Texas , Jan. 14, 2014  Luminex Corporation (Nasdaq: ... report results for the fourth quarter of 2013 on Monday, ... scheduled for release after the close of trading. ... a conference call to discuss the operating highlights and financial ...
(Date:1/14/2014)... BEVERLY HILLS, Calif. , Jan. 14, 2014 The Brandeis ... Los Angeles a premier and affordable laser tattoo ... treatment special. Dr. Brandeis, focus is in providing high quality cosmetic ... to all patients. " Southern California ...
(Date:1/14/2014)... Ore. , Jan. 14, 2014 /PRNewswire-iReach/ -- Acumed,s ... a targeting guide with accompanying instrumentation to place and ... adjunct to the soft tissue (e.g. ligament) repair or ... tissue repair heals. (Photo: http://photos.prnewswire.com/prnh/20140114/MN45636 ) ...
Breaking Medicine Technology:Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 2Acumed introduces the Scapho-Lunate Inter Carpal (SLIC) Screw System 3
... Bacterin International Holdings, Inc. ("Bacterin") (NYSE Amex: ... bone graft material and anti-infective coatings for medical applications, ... purchase agreement with Lincoln Park Capital Fund, LLC ("LPC"), ... of the agreement, Bacterin received an initial investment of ...
... -- Sinovac Biotech Ltd. (NASDAQ: SVA ), a ... appointment of Mr. Kenneth Lee as a director to the ... replace Mr. Xianping Wang who resigned from the Board due ... Principal at SAIF Partners, a leading growth capital fund focused ...
Cached Medicine Technology:Bacterin International Receives $1 million Initial Investment of $31 Million Purchase Agreement with Lincoln Park Capital Fund, LLC 2Bacterin International Receives $1 million Initial Investment of $31 Million Purchase Agreement with Lincoln Park Capital Fund, LLC 3Bacterin International Receives $1 million Initial Investment of $31 Million Purchase Agreement with Lincoln Park Capital Fund, LLC 4Sinovac Appoints Kenneth Lee to Board of Directors 2
(Date:4/17/2014)... estimated that as many as 10 million older Americans ... loneliness and isolation. , However, new research a ... older Americans for six years found that Internet ... depression by more than 30 percent. , "That,s a ... University professor of telecommunication, information studies and media who ...
(Date:4/17/2014)... April 17, 2014-- Colic affects about one in five ... numerous pediatric visits during the first several months after ... symptoms was showing promise; however, the April 1, 2014 ... Sung, Valerie) reported on a study, "Probiotics and Infant ... L reuteri for infant colic did not ...
(Date:4/17/2014)... Medicine (BUSM) have discovered that the anti-seizure drug ... The findings, reported in the American Journal ... to more effective treatments for alcoholism. , Excessive ... causes of illness and death in the U.S. ... the productivity of workers and necessitating huge health ...
(Date:4/17/2014)... researchers at UC Davis has shown that the cyclin ... cell division, also boosts the mitochondrial activity to power ... has been shown to perform both jobs. This newfound ... control cellular energy production, potentially advancing cancer care and ... the journal Developmental Cell . , "These proteins ...
(Date:4/17/2014)... led by Cesar A. Arias, M.D., Ph.D., at The ... has identified a new superbug that caused a bloodstream ... the April 17 issue of The New England ... part of a class of highly-resistant bacteria known as ... a major cause of hospital and community-associated infections. The ...
Breaking Medicine News(10 mins):Health News:Internet use can help ward off depression among elderly 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:New MRSA superbug emerges in Brazil 2
... MONDAY, Nov. 15 (HealthDay News) -- People who wear multifocal ... who wear glasses, a new study finds. Multifocal lenses ... common with age. This study included 11 volunteers, aged ... track at night. Wearing multifocal contact lenses resulted ...
... on gaming and health in adolescents, conducted by researchers ... differences linked to gaming as well as important health ... journal Pediatrics , the study is among the ... gaming and problematic gaming in a community sample of ...
... is approximately 40 percent and show no sign of ... to tackle the problem using a comprehensive and pioneering ... partnerships with the Cleveland Metropolitan School District (CMSD) and ... National Institutes of Health (NIH)-funded program will be led ...
... world,s first remote heart procedure, using a robotic arm alongside ... in Leicester. It comes six months after Dr ... procedure using the Amigo Robotic Catheter System. Dr ... consultant cardiologist and electrophysiologist at Glenfield Hospital. On ...
... , MONDAY, Nov. 15 (HealthDay News) -- Although automated external ... in public places such as restaurants, malls and airplanes, they ... of death when used in hospitals, a new study suggests. ... of heart rhythms associated with the heart attack, said researchers ...
... with the cardiac diagnostic imaging technique of myocardial perfusion imaging ... high cumulative estimated radiation dose, according to a study in ... is being released early online because it is being presented ... medical imaging has grown rapidly in recent years, but along ...
Cached Medicine News:Health News:When video games get problematic so do smoking, drug use and aggression 2Health News:Community rallies to fight obesity in Cleveland's urban youth 2Health News:Community rallies to fight obesity in Cleveland's urban youth 3Health News:Community rallies to fight obesity in Cleveland's urban youth 4Health News:Robo-op marks new world first for heart procedure 2Health News:External Defibrillators Not Much Help in Hospitals 2Health News:External Defibrillators Not Much Help in Hospitals 3Health News:Common for patients to undergo multiple cardiac imaging tests, with high cumulative radiation dose 2Health News:Common for patients to undergo multiple cardiac imaging tests, with high cumulative radiation dose 3
OHL periosteal elevator, 19 cm, 7-1/2"....
Steinhauser periosteal elevator....
Dolwick-Reich Condyle periosteal elevator, 17.5 cm, 7"....
Molt periosteal elevator #9, 18.5 cm, 7-1/4"....
Medicine Products: